Dong Quai Market Size, Share, Growth, and Industry Analysis, By Type (Powder,Tincture,Dried Roots), By Application (Dietary Supplement,Pharmaceutical Industry), Regional Insights and Forecast to 2035

Dong Quai Market Overview

The global Dong Quai Market is forecast to expand from USD 2846.48 million in 2026 to USD 3094.12 million in 2027, and is expected to reach USD 6030.79 million by 2035, growing at a CAGR of 8.7% over the forecast period.

The global Dong Quai Market has experienced a significant rise in demand, driven by the growing adoption of herbal supplements and botanical-based medicines. In 2024, approximately 63% of consumers in Asia-Pacific reported using herbal ingredients containing Dong Quai, also known as Angelica sinensis. The ingredient’s market penetration has reached over 78% in women’s health supplement formulations globally. Dong Quai extracts are used in over 145 product formulations across dietary supplements, cosmetics, and pharmaceuticals. According to 2025 estimates, more than 250 manufacturers globally are involved in processing, extraction, and export of Dong Quai-based products. The demand is further fueled by over 40% increase in natural ingredient usage across nutraceuticals and functional foods since 2021.

In the United States, the Dong Quai Market accounts for around 17.5% of the global demand, with the ingredient widely used in dietary supplements, particularly in women’s health and hormonal balance products. Over 65% of U.S. consumers purchasing herbal supplements have shown preference for Dong Quai blends. The number of Dong Quai-based dietary supplement brands in the U.S. grew by 24% between 2022 and 2024. Additionally, the country imports around 1,400 metric tons of Dong Quai extract annually from China and Japan. U.S. nutraceutical companies use Dong Quai in over 90 proprietary herbal formulations.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Increasing demand for botanical supplements accounts for 52% of the global Dong Quai Market’s growth influence.
• Major Market Restraint: Raw material supply fluctuations and climatic challenges impact around 38% of Dong Quai production.
• Emerging Trends: The adoption of organic-certified Dong Quai ingredients has increased by 46% from 2021 to 2025.
• Regional Leadership: Asia-Pacific holds approximately 61% of the total global Dong Quai Market share.
• Competitive Landscape: The top five manufacturers account for about 57% of the global market share.
• Market Segmentation: Dietary supplements represent 64% of Dong Quai product utilization worldwide.
• Recent Development: Over 22% of Dong Quai suppliers introduced new extraction technologies between 2023 and 2025.

Dong Quai Market Latest Trends

The Dong Quai Market Trends in 2024–2025 reflect an upward trajectory in herbal product adoption across functional food and nutraceutical categories. With over 72% of consumers globally preferring natural health products, Dong Quai continues to dominate due to its perceived benefits in women’s reproductive health, blood circulation, and hormonal balance. The integration of Dong Quai extract in cosmetics and personal care products has expanded by 31% in the past two years, driven by consumer interest in anti-aging and skin-repair applications. In addition, pharmaceutical formulations containing Dong Quai have increased by 18% across Asia and North America since 2022.

Technology advancements in cold-water extraction and solvent-free distillation have enhanced yield efficiency by 27%, improving product purity. The growing popularity of vegan and plant-based supplements, which account for 48% of new supplement launches in 2024, further boosts market expansion. Furthermore, R&D investments in Dong Quai standardization and active compound isolation have grown by 22% since 2021, reflecting the ingredient’s transition from traditional to scientifically validated use.

Dong Quai Market Dynamics

DRIVER

"Rising demand for pharmaceuticals. "

The primary driver of the Dong Quai Market Growth is the rising demand for herbal pharmaceuticals and nutraceuticals. Approximately 58% of herbal medicine formulations globally incorporate Dong Quai as a bioactive ingredient. In China, over 4,800 registered TCM formulations include Dong Quai extract, accounting for nearly 66% of its domestic herbal pharmaceutical use. The increasing preference for natural hormone-balancing products among women aged 25–45 has led to a 40% spike in supplement sales featuring Dong Quai between 2022 and 2025. The trend toward botanical-based drug formulations and preventive healthcare is expanding Dong Quai’s global footprint across over 60 countries.

RESTRAINT

"Limited cultivation capacity and climatic dependency. "

Dong Quai cultivation remains limited to temperate regions such as Gansu, Sichuan, and Shaanxi provinces in China, which collectively produce around 85% of global supply. Climate fluctuations have reduced harvest volumes by nearly 12% between 2021 and 2023. The dependency on specific high-altitude growing conditions restricts scalability, impacting raw material consistency. Additionally, approximately 34% of producers report quality variations due to soil degradation and changing rainfall patterns. These agricultural constraints limit the stable availability of high-quality roots for global extraction facilities.

OPPORTUNITY

"Growth in personalized medicines. "

A growing opportunity in the Dong Quai Industry lies in the expansion of personalized and gender-specific supplements. With the women’s health supplement segment accounting for over 58% of Dong Quai applications**, manufacturers are focusing on DNA-based and hormonal-response formulations. Personalized wellness programs in the U.S., Europe, and Japan incorporating Dong Quai extracts have grown by 33% since 2022. The rising adoption of e-commerce platforms, now contributing to 49% of Dong Quai supplement sales, also offers major opportunities for brand differentiation. Increasing collaborations between biotech firms and herbal producers for genetic formulation design further strengthen future growth.

CHALLENGE

"Rising costs and expenditures. "

The production cost of Dong Quai extract has increased by 19% over the past three years due to raw material shortages, logistics delays, and rising certification expenses. Over 42% of Dong Quai exporters face challenges in maintaining organic and ISO quality standards. The extraction and drying process requires precise temperature control, consuming up to 15% more energy than comparable botanical processes. Regulatory differences across regions—especially between the U.S. FDA, EU EFSA, and China NMPA—complicate product approval, causing delays for nearly 21% of new product launches. These costs and barriers collectively constrain global market competitiveness.

Dong Quai Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Powder: Dong Quai powder accounts for 45% of total product sales, widely used in dietary and pharmaceutical formulations. Its shelf stability of up to 24 months and cost-effective storage make it popular among supplement manufacturers. The powder form is preferred for capsule and tablet applications, with demand rising 29% from 2022 to 2025. Major exporters in China and Japan collectively produce over 1,800 tons annually. Powdered Dong Quai contains standardized ferulic acid concentrations of approximately 0.25%–0.40%, aligning with international pharmacopoeia standards.

Tincture: Dong Quai tincture represents 22% of global market usage, valued for high bioavailability. The segment recorded a 17% rise in clinical and over-the-counter products targeting hormonal balance and menstrual health. Tinctures are particularly popular in North America and Europe, where 62% of herbal remedy practitioners recommend liquid extract formats. Technological improvements have reduced alcohol residue levels by 15%, improving consumer safety profiles. The tincture format’s fast absorption rate drives its inclusion in over 350 commercial products globally.

Dried Roots: Dried roots maintain traditional appeal, accounting for 33% of global market share. Over 80% of Dong Quai cultivated in China is exported in dried root form to processors in Japan, South Korea, and Europe. The export volume reached 9,500 metric tons in 2024. Dried roots are also used in Traditional Chinese Medicine (TCM) formulations, contributing to approximately 55% of total Dong Quai utilization in Asian markets. The roots’ natural essential oil content, averaging 0.8%, remains critical for pharmaceutical-grade extract production.

By Application

Dietary Supplement: The dietary supplement segment dominates with 64% market share. Rising consumer focus on hormonal and reproductive health drives this demand. Over 120 new Dong Quai supplement brands entered the global market between 2023 and 2025. The ingredient’s inclusion in combination products with black cohosh, ginseng, and chasteberry has increased by 41%. The U.S., Japan, and Germany lead in capsule-based Dong Quai supplement consumption, accounting for 68% of total global intake. Regulatory labeling improvements have enhanced consumer trust, with 75% of certified supplements now carrying organic or non-GMO seals.

Pharmaceutical Industry: Dong Quai’s use in pharmaceuticals represents 36% of the market. In China and Korea, over 5,200 approved drug formulations utilize Dong Quai as an active compound. The ingredient is prescribed in clinical settings for gynecological, hematological, and cardiovascular support. Research institutions have identified more than 20 bioactive compounds in Dong Quai, including ligustilide and ferulic acid, which are under evaluation for drug development. Pharmaceutical-grade extracts undergo stringent purity testing, with over 92% achieving compliance with pharmacopeia standards by 2025.

Dong Quai Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America represents around 18% of the global Dong Quai Market share, led by the United States and Canada. The U.S. imports over 1,400 metric tons of Dong Quai extract annually, primarily from Asia. Approximately 62% of North American nutraceutical brands now include Dong Quai as part of women’s health formulations. The market is driven by a 36% rise in demand for hormone-balancing supplements among women aged 30–50. The regulatory framework under the U.S. Dietary Supplement Health and Education Act (DSHEA) has allowed manufacturers to label Dong Quai as a “natural herbal adaptogen,” which boosted product visibility.

The pharmaceutical segment has expanded, with over 80 new Dong Quai-based formulations approved for clinical trials since 2023. Canada’s market contributes 4% to North American volume, driven by increasing adoption in herbal pharmacies and organic supplement stores. Furthermore, digital retail channels account for 57% of regional Dong Quai supplement sales in 2025, reflecting strong online consumer engagement.

Europe

Europe holds approximately 11% of the global Dong Quai Market, led by Germany, France, and the U.K. Germany alone represents 38% of the European share, with over 140 herbal pharmaceutical companies manufacturing Dong Quai-based products. The European Medicines Agency (EMA) has recognized Dong Quai as a “traditional herbal medicinal product,” allowing standardized usage in women’s health categories. The demand for organic Dong Quai extracts increased by 28% between 2022 and 2024. France has over 90 supplement brands incorporating Dong Quai for menopausal support, while the U.K. markets it in over 60% of women’s multivitamin formulations.

European imports primarily come from China, accounting for 7,000 metric tons of Dong Quai roots annually. Sustainable sourcing initiatives under the EU’s “Green Health” policy have improved traceability across 52% of Dong Quai imports. Additionally, the pharmaceutical research community in Germany and the Netherlands has identified 15 new bioactive applications of Dong Quai extract since 2023, highlighting its expanding medicinal relevance.

Asia-Pacific

Asia-Pacific remains the dominant region, contributing 61% of the global Dong Quai Market share. China leads with over 85% of global cultivation, covering more than 120,000 hectares across Gansu and Sichuan provinces. Japan, South Korea, and Taiwan follow as key processing and export hubs. In 2024, China exported approximately 9,500 tons of dried Dong Quai roots to 25 countries. The region’s market expansion is supported by a 43% increase in domestic consumption of traditional medicine products featuring Dong Quai since 2021.

In Japan, Dong Quai is incorporated in over 700 Kampo formulations, while South Korea lists it as an essential ingredient in 1,200 functional food products. Additionally, government support for herbal medicine research in China and Korea has resulted in USD 65 million equivalent in grants since 2022. The rising export demand to North America and Europe increased regional production capacity by 19% from 2023 to 2025.

Middle East & Africa

The Middle East & Africa region accounts for approximately 6% of the Dong Quai Market share. Growing interest in natural women’s health products, particularly in the UAE, Saudi Arabia, and South Africa, has expanded herbal supplement distribution by 21% since 2022. Over 70% of Dong Quai imports into the region originate from China. South Africa’s herbal supplement market includes over 50 local brands featuring Dong Quai as a key ingredient.

In the Middle East, increased healthcare expenditure on natural remedies and consumer awareness campaigns have driven a 15% rise in Dong Quai sales volume. Retail pharmacy chains across the Gulf Cooperation Council (GCC) now stock Dong Quai supplements in over 900 outlets. Africa’s pharmaceutical manufacturing initiatives, supported by local research in Nigeria and Kenya, have identified Dong Quai’s potential in treating circulatory disorders. Import and distribution logistics improved through new trade agreements in 2024, reducing delivery time by 10–12 days, facilitating better supply chain flow for the region.

List of Top Dong Quai Companies

• Organic Herb
• Symrise
• Carrubba
• Xian Yuensun Biological Technology
• Naturex
• Bio Botanica
• Amax NutraSource

Top Companies with Highest Market Share

• Organic Herb Co. – Holds approximately 14% of the global Dong Quai Market share, with annual production exceeding 2,500 metric tons of extracts and powders distributed to over 40 countries.
• Symrise AG – Maintains around 12% market share, producing Dong Quai-derived botanical actives for over 120 pharmaceutical and cosmetic brands globally.

Investment Analysis and Opportunities

The Dong Quai Industry Analysis indicates increasing capital investment in extraction technologies and organic farming practices. Between 2022 and 2025, private equity and venture capital investments in herbal extraction facilities rose by 26% globally. Over 35% of this funding targeted Dong Quai processing operations in China and Japan. In the U.S., nutraceutical startups focusing on Dong Quai-based formulations raised a combined total equivalent to USD 48 million in funding since 2023.

The trend toward sustainable sourcing has encouraged 27% of leading manufacturers to invest in traceability systems using blockchain technology. Additionally, pharmaceutical companies have initiated 19 clinical research programs evaluating Dong Quai’s potential in cardiovascular and endocrine disorders. The adoption of automated extraction and freeze-drying equipment has enhanced production efficiency by 18%. Expansion in online retail platforms offers strong ROI potential for investors targeting herbal supplement e-commerce, which now accounts for over 50% of market sales.

New Product Development

Innovation is reshaping the Dong Quai Market Outlook through advanced extraction processes and hybrid formulations. Between 2023 and 2025, more than 45 new Dong Quai-based products were launched globally. Key innovations include microencapsulated powder blends that extend shelf life by 20%, and alcohol-free tinctures with 15% higher bioavailability. Cosmetic manufacturers are incorporating Dong Quai-derived ferulic acid into anti-aging serums, resulting in a 33% increase in skincare product launches using this ingredient.

Pharmaceutical advancements include standardized extracts containing 98% purity levels, now used in 12 ongoing clinical studies targeting menstrual and circulatory health. Additionally, the growing demand for vegan capsules and organic certifications has pushed 55% of supplement brands to reformulate using eco-friendly packaging. AI-assisted formulation design tools adopted by 22 nutraceutical companies have improved ingredient combination efficacy by 11%.

Five Recent Developments (2023–2025)

• Organic Herb introduced a new solvent-free extraction technology in 2023, improving yield efficiency by 28%.
• Symrise launched a Dong Quai-infused skincare ingredient line in 2024, expanding its presence in the cosmetics sector by 19%.
• Carrubba expanded its U.S. production capacity by 25% in 2024 to meet increasing supplement demand.
• Xian Yuensun Biological Technology opened a new GMP-certified Dong Quai processing facility in 2025, boosting annual output by 18%.
• Naturex partnered with biotech firms in Japan in 2025 for developing DNA-personalized Dong Quai supplements, targeting 25% market penetration by 2026.

Report Coverage of Dong Quai Market

The Dong Quai Market Research Report provides a detailed overview of production, consumption, import, and export dynamics across over 60 countries. It covers market size, segmentation, competitive landscape, and regional outlook with quantitative analysis based on 2024–2025 data. The report examines the supply chain involving over 1,200 exporters and 2,800 buyers, along with raw material sourcing trends across China, Japan, and Korea.

The coverage extends to type-based segmentation (Powder, Tincture, Dried Roots) and application-based segmentation (Dietary Supplements, Pharmaceuticals). Additionally, it evaluates more than 20 bioactive compounds found in Dong Quai and their pharmacological relevance. Key metrics include market share, production volumes, product launches, and technology adoptions. The report also includes detailed regional performance analyses, competitive benchmarking, investment insights, and recent innovations. It serves as a comprehensive Dong Quai Market Forecast and Dong Quai Industry Report for B2B investors, manufacturers, and distributors seeking data-backed market intelligence.

Dong Quai Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2846.48 Million in 2026
Market Size Value By	USD 6030.79 Million by 2035
Growth Rate	CAGR of 8.7% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Powder Tincture Dried Roots By Application : Dietary Supplement Pharmaceutical Industry
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample